A new medication that was thought to hold promise for non-Hodgkin lymphoma has been stopped. Pfizer announced it has halted its trial of the investigational compound inotuzumab ozogamicin.
Stem cell transplants can – and do – save the lives of very sick kids. New research has discovered that the transplant is often just the start of hospital stays for these young patients.
Fear that the treatment for one condition might cause another condition, like cancer, could prevent people from taking needed medications. But should this be a concern for lupus patients?
Being tired after any type of cancer therapy is to be expected. Some survivors of childhood cancer, though, can still be battling fatigue many years later.
The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.
